RCA CEO, Christine Cockburn, interviewed with i98 Power FM radio on the need for a pan-tumour approach to cancer care
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wish list failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
RCA CEO, Christine Cockburn, interviewed with i98 Power FM radio on the need for a pan-tumour approach to cancer care
-
Narrated by:
-
Written by:
About this listen
People living with cancer urgently need action on expanded access to precision therapies
Over the past two decades, our ability to rapidly obtain genomic information on an individual and their cancer has led to a dramatic shift in how we can diagnose, treat, monitor and prevent cancer, leading to an era of precision oncology.
With this expanded knowledge of cancer there are several promising treatments that can specifically target the drivers of an individual’s cancer, that are already under review through Australia’s health technology assessment process. Too many people living with cancer in Australia still don’t have access; and they can’t afford to wait.